| Filed On | Filing |
|---|---|
| 06 Nov 2026 |
Form 4: Velden Claus Vander, Director
Granted 50,000 Stock Option (Right to Buy) |
| 06 Nov 2026 |
Form 4: Donhauser Peter D.o., Director
Granted 50,000 Stock Option (Right to Buy) |
| 06 Nov 2026 |
Form 4: Kellmeyer Terrie, Director
Granted 200,000 Stock Option (Right to Buy) |
| 06 Nov 2026 |
Form 4: Paeger Axel, Director
Granted 50,000 Stock Option (Right to Buy) |
| 03 Nov 2026 |
8-K: Departure/Election of Directors or Officers; Compensation
Anavex Life Sciences Names Terrie Kellmeyer, Ph.D., as President and Chief Executive Officer and Member of the Board of Directors |
| 02 Nov 2026 |
8-K: Departure/Election of Directors or Officers; Compensation; Other Events
I write to inform you of my decision to resign from my position as a member of the Board of Directors of Anavex Life Sciences, where I am the chairman of the Board; and a member of the Audit Committee. My resignation is effective on Octo... |
| 20 Oct 2026 |
8-K: Other Events
Clinical conduct of both blarcamesine (ANAVEX®2-73) studies in healthy volunteers is now complete, data are expected to support clinical pharmacology characterization across pipeline programs |
| 15 Oct 2026 |
8-K: Other Events
Anavex now has open INDs in all three core indications: Alzheimer’s disease, Rett syndrome, and Fragile X syndrome |
| 05 Oct 2026 |
Form 3: Senderowicz Adrian, Director
No securities owned |
| 05 Oct 2026 |
Form 3: Patel Gautam, Director
No securities owned |
| 28 Sep 2026 |
Form 4: Boenisch Sandra, PFO & Treasurer
Granted 95,000 Stock Option (Right to Buy) |
| 28 Sep 2026 |
8-K: Changes in Control of Registrant; Submission of Matters to a Vote of Security Holders
As further described under Item 5.07 of this Current Report on Form 8-K, Anavex Life Sciences Corp. (“Anavex” or the “Company”) held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”) on September 24, 2026. The election of th... |
| 21 Sep 2026 | DFAN14A |
| 18 Sep 2026 | DFAN14A |
| 17 Sep 2026 | DFAN14A |
| 15 Sep 2026 | FORM DEFA14A |
| 15 Sep 2026 | DFAN14A |
| 14 Sep 2026 | FORM DEFA14A |
| 10 Sep 2026 | DFAN14A |
| 10 Sep 2026 | DFAN14A |
Loading...